Written By:
MS, BCBA
Introduction
Walk into any health food store or scroll through any autism parent group online, and you’re likely to encounter discussions about sulforaphane, a compound derived from broccoli sprouts that has generated genuine scientific interest as a possible support for autism symptoms. The headlines can sound exciting: “Broccoli extract improves autism behaviors.” But what does the research actually show, and what should families in Maryland make of it?
This article walks through the current evidence carefully. Sulforaphane is not an established, FDA-approved treatment for autism. It is an area of emerging research with promising early signals and real limitations. Our goal is to help parents, individuals with autism, therapists, and educators understand what is genuinely known, what is still uncertain, and how this fits alongside evidence-based interventions.
What Is Sulforaphane?
Sulforaphane is a naturally occurring compound, technically an isothiocyanate, produced when you crush, chew, or chop cruciferous vegetables like broccoli, kale, and Brussels sprouts. Broccoli sprouts (the young seedlings, harvested a few days after germination) contain significantly higher concentrations than mature broccoli, which is why nearly all clinical studies use broccoli sprout extract rather than the vegetable itself.
In the body, sulforaphane activates a cellular pathway called Nrf2, which in turn switches on genes involved in antioxidant defense, detoxification, and inflammation control. Researchers have studied it for years in connection with cancer prevention, cardiovascular health, and now neurodevelopmental conditions.
Why Researchers Became Interested in Sulforaphane for Autism
The interest didn’t come out of nowhere. Over the past two decades, researchers have repeatedly documented certain biological patterns in subsets of individuals with autism spectrum disorder, including:
- Elevated oxidative stress, an imbalance between free radicals and antioxidants in the body
- Lower levels of glutathione, a key antioxidant
- Differences in mitochondrial function, the cells’ energy-producing machinery
- Markers of neuroinflammation in some studies
Sulforaphane, in laboratory and animal studies, addresses each of these pathways. It boosts glutathione production, supports mitochondrial function, reduces inflammatory markers, and activates the heat shock response, which is intriguing because parents of children with autism have long reported that behaviors sometimes improve during fevers. The “fever effect” was one of the original observations that prompted researchers to investigate sulforaphane.
In other words, there was a biologically plausible reason to test it. That’s the foundation for any legitimate research question.
The Key Clinical Studies
The 2014 Johns Hopkins Trial
The study that put sulforaphane on the map was published in 2014 in the Proceedings of the National Academy of Sciences by Singh and colleagues. It was a placebo-controlled, double-blind, randomized trial involving 44 young men with moderate to severe autism, aged 13 to 27. Twenty-nine received daily sulforaphane (50–150 µmol) for 18 weeks; 15 received a placebo.
The results were notable. Of the 26 participants who received sulforaphane, 65% showed significant improvements in behavior, while none of those on placebo experienced significant changes. Improvements were observed in aberrant behavior, social responsiveness, communication, irritability, hyperactivity, and stereotypy. Daily treatment with sulforaphane for 4–18 weeks resulted in significant improvements in aberrant behavior and social impairment in a majority of young males diagnosed with moderate to severe autism, and this improvement regressed upon cessation of treatment.
That last detail matters: when participants stopped taking sulforaphane, scores returned toward pretreatment levels. The reversibility supports the idea that the compound itself was driving the change, not chance.
Follow-Up Research in Children
A reasonable next question was: Does this work in younger children? A 2020 follow-up trial led by researchers, including Dr. Andrew Zimmerman, investigated this in 57 children aged 3 to 12. The results were more mixed. Treatment effects on the primary outcome measure were not significant between the sulforaphane and placebo groups. However, caregivers’ assessments of children taking sulforaphane showed statistically significant improvements compared to those taking a placebo on the Aberrant Behavior Checklist but not the Social Responsiveness Scale.
The researchers also documented significant changes with sulforaphane compared to placebo in biomarkers of glutathione redox status, mitochondrial respiration, inflammatory markers, and heat shock proteins. So the underlying biology shifted, even if the clinical picture was more modest than in the original adult study.
Other Trials
A randomized clinical trial conducted in China with 108 participants reported behavioral improvements consistent with the Johns Hopkins findings. However, a study of children aged 3–7 with ASD showed inconsistent results, with no significant clinical improvement.
2024 systematic review and meta-analysis pooled six randomized controlled trials and concluded that sulforaphane showed modest benefits for certain behavioral measures, particularly irritability and hyperactivity, with a generally favorable safety profile. But the same review cautioned about small sample sizes, heterogeneity in outcome measures, and the need for larger, longer studies before any clinical recommendations can be made.
What the Research Doesn’t Yet Tell Us
This is where honesty matters. Despite encouraging early signals, several major gaps remain:
Small sample sizes. Most trials have involved fewer than 100 participants. By the standards required to establish a treatment, the evidence base is still preliminary.
Heterogeneity in autism. Autism is not a single condition with a single biological signature. The biological subgroups that might respond to sulforaphane, for example, those with documented oxidative stress markers, haven’t been clearly identified, so we can’t predict in advance who is most likely to benefit.
Inconsistent outcomes across age groups. Adult and adolescent studies have generally shown stronger effects than studies in younger children. The reasons aren’t yet clear.
Optimal dose, formulation, and duration are unknown. Different studies have used different preparations, broccoli sprout extract, broccoli seed extract, stabilized sulforaphane, with different concentrations. Bioavailability varies significantly between products.
No long-term safety data in children. Short-term safety in trials has been good, with mild gastrointestinal side effects being most common. But multi-year safety data simply doesn’t exist.
It is a supplement, not an FDA-approved medication. This means manufacturing standards vary widely between brands. What’s on the label isn’t always what’s in the bottle.
How This Fits With Evidence-Based Interventions
This is the part we want to be very direct about. Sulforaphane research is interesting and worth following. It is not a substitute for the interventions that have decades of evidence behind them, particularly Applied Behavior Analysis (ABA) therapy, speech-language therapy, occupational therapy, and educational support.
In our parent training sessions, we often hear from families exploring supplements, dietary changes, and emerging compounds. The conversation we always come back to is this: even if a compound like sulforaphane eventually proves to offer modest biological support, the skills your child builds in structured behavioral therapy, communication, daily living skills, social engagement, and emotional regulation are not produced by any supplement. Skill-building is what changes a life trajectory.
We’ve seen families across Maryland make the most progress when they treat emerging research with curiosity but anchor their plan around what’s proven. A child who builds functional communication through targeted ABA programming gains something concrete and lasting. That foundation isn’t replaceable.
If a family is interested in exploring sulforaphane or any nutraceutical, the right next step is a conversation with the child’s pediatrician or a developmental pediatrician, not a switch in their core therapy plan.
Practical Considerations for Families
If you’re a parent reading about sulforaphane and wondering what to do, here are some grounded steps:
Talk to your child’s medical provider first. This is especially important if your child takes any medications, since supplements can interact with prescription drugs. Some sources note potential interactions with medications metabolized by the liver.
Be cautious about product quality. Sulforaphane is unstable and degrades with heat and time. Many supplements on the shelf contain far fewer active compounds than the label suggests. Look for third-party tested products, and recognize that even then, results vary.
Watch for marketing that overpromises. Any product claiming to “treat” autism with a supplement is making a claim that science does not support. The legitimate research framing is “may offer modest behavioral benefits in some individuals”, a much narrower claim.
Document what you observe. If you and your child’s medical team decide to try sulforaphane, treat it like an experiment. Keep brief notes on sleep, behavior, and any side effects so you can evaluate honestly after a defined period.
Continue evidence-based therapies. Whatever you try on the medical or nutritional side, the structured skill-building of ABA, speech therapy, and educational support should continue uninterrupted.
Conclusion
Sulforaphane research represents a real and interesting scientific question: can a naturally occurring compound that addresses oxidative stress, inflammation, and mitochondrial function provide measurable behavioral support for individuals with autism? Early studies, particularly the 2014 Johns Hopkins trial, produced encouraging signals. Follow-up research has been more mixed, with effects that vary by age, dose, and outcome measure.
Where does that leave families? With reason for cautious interest, not certainty. Sulforaphane is not a treatment for autism in any clinical sense. It is a compound under investigation, with a plausible biological rationale and a small but growing evidence base. The right framing is “what the research currently shows”, which is exactly the framing this article has tried to maintain.
In the meantime, the interventions with the strongest evidence, Applied Behavior Analysis, parent training, early intervention, and individualized educational support, remain the foundation. Emerging research can be watched with interest, discussed with your medical team, and integrated thoughtfully if and when the evidence matures.
Long-term safety data in children is still limited, which is one reason consultation with a pediatrician before starting any supplement is essential.
Get Support From a Trusted ABA Provider in Maryland
At Admire ABA, we work with families across Maryland, including the Baltimore, Silver Spring, and Columbia areas, to build evidence-based, individualized care plans that prioritize what truly moves the needle for children with autism. Whether you’re navigating a new diagnosis, exploring early intervention, or balancing your child’s care plan alongside emerging research questions like the ones discussed in this article, our team is here to help. Our services include in-home ABA therapy, parent training, daycare-based ABA, weekend ABA, early intervention ABA therapy, and diagnostic services, all delivered by clinicians who understand that good outcomes come from skilled, consistent, family-centered care.
Have questions or want to talk through your options? Contact us today!
Frequently Asked Questions
Is sulforaphane an approved treatment for autism?
No. Sulforaphane is not approved by the FDA as a treatment for autism. It is a dietary compound that has been studied in a small number of clinical trials. While some studies have shown modest behavioral improvements, the evidence base is preliminary, and sulforaphane should not replace established interventions like ABA therapy or be started without consulting your child’s medical provider.
Can my child just eat more broccoli instead of taking a supplement?
Eating broccoli, broccoli sprouts, and other cruciferous vegetables is healthy and worthwhile, but the doses of sulforaphane used in clinical autism studies are significantly higher than what’s reasonably obtained from food. Broccoli sprouts contain the most, while mature broccoli contains relatively little. That said, no research currently shows that any dietary level of sulforaphane affects autism symptoms. Clinical trial doses have used concentrated extracts.
What are the known side effects of sulforaphane in children?
In published clinical trials, sulforaphane has generally been well tolerated. The most common side effects reported were mild and included gastrointestinal symptoms like gas, constipation, diarrhea, occasional vomiting, and rare reports of irritability, insomnia, or intolerance of taste and smell.
SOURCES:
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10800504/
- https://www.healthline.com/nutrition/sulforaphane
- https://www.webmd.com/vitamins-supplements/sulforaphane
- https://en.wikipedia.org/wiki/Sulforaphane
- https://www.sciencedirect.com/science/article/pii/S1756464623002451
